Characterization of response to nivolumab plus ipilimumab (N+I) or sunitinib (S) in patients (pts) with previously untreated advanced renal cell carcinoma (aRCC): CheckMate 214 Meeting Abstract
| Authors: | Rini, B. I.; Tannir, N. M.; Escudier, B.; McDermott, D. F.; Grimm, M. O.; Porta, C.; Powles, T.; Kollmannsberger, C. K.; Gurney, H. P.; Tykodi, S. S.; Harrison, M.; Heng, D. Y. C.; Grünwald, V.; Choueiri, T. K.; Mekan, S.; McHenry, M. B.; Hammers, H. J.; Motzer, R. J.; George, S. |
| Abstract Title: | Characterization of response to nivolumab plus ipilimumab (N+I) or sunitinib (S) in patients (pts) with previously untreated advanced renal cell carcinoma (aRCC): CheckMate 214 |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy283.084 |
| Language: | English |
| ACCESSION: | WOS:000459277302058 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy283.084 |
| Notes: | Meeting Abstract: 875P -- Appears on page viii309-viii310 of the abstract book -- Source: Wos |
